Thiol-Reactive PEG Lipid Production via Mild Acid Deprotection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing thiol-reactive polyoxyalkylene-modified lipids result in high monoacyl lipid content, leading to biotoxicity and liposome destabilization, which is undesirable for drug delivery systems.
Innovation Solution
A method involving a deprotecting step prior to coupling the polyoxyalkylene chain, using specific protective groups and acids to minimize monoacyl lipid production, resulting in a high-purity thiol-reactive polyoxyalkylene-modified lipid with reduced monoacyl content.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional deprotection methods (oxidative, acidic, or alkaline conditions) are used to remove protective groups from polyoxyalkylene chains, then the protective group is successfully removed, but ester groups in the lipid are decomposed leading to monoacyl lipid formation
Solution Approach 1:
The patent changes the chemical parameters of the deprotection process by using mild acidic conditions (pH 4-6) instead of conventional strong oxidative, acidic, or alkaline conditions. This parameter change allows selective removal of the protective group from the polyoxyalkylene chain while preserving the ester groups in the lipid, thereby preventing monoacyl lipid formation and achieving high purity product
Solution Approach 2:
The patent introduces a specific protective group configuration where the protective group is attached to the polyoxyalkylene chain through a labile bond that can be selectively cleaved under mild conditions. This intermediary structure enables differential deprotection: the protective group on the polyoxyalkylene chain is removed while the ester groups remain intact, solving the selectivity problem
2Reliability
If thiol-reactive PEG phospholipids are used to modify liposomes, then liposome stability is improved, but phospholipid charge repels cell membranes reducing cellular incorporation efficiency
Solution Approach 1:
The patent applies local quality by using diacyl glycerol-type PEG lipids where only the head group region is modified with PEG and thiol-reactive functionality, while the acyl chain region maintains neutral properties. This localized modification provides liposome stability through PEG shielding without the charge-related cellular incorporation problems of phospholipids
Solution Approach 2:
The patent creates a composite lipid structure combining diacyl glycerol backbone with PEG chain and thiol-reactive group. This composite material integrates the stability benefits of PEG modification with the neutral charge characteristics of diacyl glycerol, achieving both liposome stability and efficient cellular incorporation
3Adaptability or versatility
If PEG is bonded to amino groups of lysine side chains to graft target molecules, then target recognition is achieved, but active sites may be deactivated
Solution Approach 1:
The patent inverts the conventional approach by making the PEG lipid itself thiol-reactive rather than modifying the target molecule with PEG. This inversion allows the PEG lipid to react with thiol groups on target molecules (or remain unreacted for passive targeting) while avoiding the problem of PEG bonding to and deactivating lysine amino groups, thus preserving active site functionality
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach produces a thiol-reactive polyoxyalkylene-modified lipid with low monoacyl lipid content, reducing biotoxicity and self-degradation of liposomes, making it suitable for drug delivery systems.
Implementation Method 1
a compound represented by formula (3) by deprotecting a chemically protected amino group of a compound represented by formula (2) with a sulfonic acid
Implementation Method 2
Z is a group containing either maleimide or iodoacetamide
Data Source
AI summary
Provided are a thiol-reactive polyoxyalkylene-modified lipid which can be used to chemically modify bioactive substances and which can be used for drug delivery systems such as liposomes and a method for producing the same. The polyoxyalkylene-modified lipid is represented by the following formula (1):(wherein, R1 and R2 are hydrocarbon groups which are the same as or different from each other and which contain 4 to 24 carbon atoms, R3 is a divalent hydrocarbon group containing 1 to 6 carbon atoms, OA is oxyalkylene groups containing 2 to 4 carbon atoms, n is the average addition mole number of the oxyalkylene groups and is 5 to 1,000, and Z is a group containing either maleimide or iodoacetamide.)